# NAPROXEN
> **ANDA091305** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2011-08-24
## Drug
- **FDA Application Number:** ANDA091305
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN
- **Generic name:** NAPROXEN
- **Active ingredients:** NAPROXEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Exelan Pharmaceuticals, Inc.
- **First approval:** 2011-08-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091305)
---
*MORVS · CC0 1.0*